Marshall Wace, LLP Becton Dickinson & CO Transaction History
Marshall Wace, LLP
- $78.4 Billion
- Q4 2024
A detailed history of Marshall Wace, LLP transactions in Becton Dickinson & CO stock. As of the latest transaction made, Marshall Wace, LLP holds 79,610 shares of BDX stock, worth $16.4 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
79,610
Previous 57,181
39.22%
Holding current value
$16.4 Million
Previous $13.8 Million
31.01%
% of portfolio
0.02%
Previous 0.02%
Shares
26 transactions
Others Institutions Holding BDX
# of Institutions
1,813Shares Held
259MCall Options Held
1.2MPut Options Held
1.09M-
Vanguard Group Inc Valley Forge, PA26.7MShares$5.5 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY22.3MShares$4.58 Billion0.12% of portfolio
-
State Street Corp Boston, MA14.1MShares$2.9 Billion0.13% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.3MShares$2.54 Billion0.32% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD12.1MShares$2.49 Billion1.7% of portfolio
About BECTON DICKINSON & CO
- Ticker BDX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 285,195,008
- Market Cap $58.7B
- Description
- Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...